That's exactly right SSV.
Your so-called assumptions are entirely consistent with my reaesrch.
Demand trends showed up in the last quarterly - and will be even more evident in the current quarter (as will be confirmed late Jan). Also apparent very large backlog in supply to distributors.
And the main thing - all this while one of the key products (oraline) is essentially off the market (until FDA clearance)
- Forums
- ASX - By Stock
- SBN
- placement
placement, page-23
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)